Euphorbetin

Details

Top
Internal ID 3b92a9fb-9a0f-41ce-bee8-c590b1cb84c8
Taxonomy Benzenoids > Benzene and substituted derivatives > Biphenols
IUPAC Name 5-(6,7-dihydroxy-2-oxochromen-5-yl)-6,7-dihydroxychromen-2-one
SMILES (Canonical) C1=CC(=O)OC2=C1C(=C(C(=C2)O)O)C3=C(C(=CC4=C3C=CC(=O)O4)O)O
SMILES (Isomeric) C1=CC(=O)OC2=C1C(=C(C(=C2)O)O)C3=C(C(=CC4=C3C=CC(=O)O4)O)O
InChI InChI=1S/C18H10O8/c19-9-5-11-7(1-3-13(21)25-11)15(17(9)23)16-8-2-4-14(22)26-12(8)6-10(20)18(16)24/h1-6,19-20,23-24H
InChI Key MFAPGDLENWJYSK-UHFFFAOYSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C18H10O8
Molecular Weight 354.30 g/mol
Exact Mass 354.03756727 g/mol
Topological Polar Surface Area (TPSA) 134.00 Ų
XlogP 2.10
Atomic LogP (AlogP) 2.39
H-Bond Acceptor 8
H-Bond Donor 4
Rotatable Bonds 1

Synonyms

Top
35897-99-5
5-(6,7-dihydroxy-2-oxochromen-5-yl)-6,7-dihydroxychromen-2-one
SCHEMBL18172254
HY-N7671
AKOS040763728
CS-0135174

2D Structure

Top
2D Structure of Euphorbetin

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8557 85.57%
Caco-2 - 0.8926 89.26%
Blood Brain Barrier - 0.8500 85.00%
Human oral bioavailability + 0.6714 67.14%
Subcellular localzation Mitochondria 0.7979 79.79%
OATP2B1 inhibitior - 0.6711 67.11%
OATP1B1 inhibitior + 0.9059 90.59%
OATP1B3 inhibitior + 0.9842 98.42%
MATE1 inhibitior - 0.7800 78.00%
OCT2 inhibitior - 0.9250 92.50%
BSEP inhibitior - 0.7572 75.72%
P-glycoprotein inhibitior - 0.8225 82.25%
P-glycoprotein substrate - 0.9544 95.44%
CYP3A4 substrate - 0.6632 66.32%
CYP2C9 substrate - 0.8157 81.57%
CYP2D6 substrate - 0.8422 84.22%
CYP3A4 inhibition - 0.8928 89.28%
CYP2C9 inhibition + 0.7780 77.80%
CYP2C19 inhibition - 0.7801 78.01%
CYP2D6 inhibition - 0.9647 96.47%
CYP1A2 inhibition - 0.7116 71.16%
CYP2C8 inhibition - 0.7427 74.27%
CYP inhibitory promiscuity - 0.9223 92.23%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.6958 69.58%
Eye corrosion - 0.9919 99.19%
Eye irritation + 0.9253 92.53%
Skin irritation + 0.5000 50.00%
Skin corrosion - 0.9479 94.79%
Ames mutagenesis - 0.5900 59.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8101 81.01%
Micronuclear + 0.9200 92.00%
Hepatotoxicity + 0.6875 68.75%
skin sensitisation - 0.8756 87.56%
Respiratory toxicity - 0.5000 50.00%
Reproductive toxicity + 0.6778 67.78%
Mitochondrial toxicity + 0.7500 75.00%
Nephrotoxicity - 0.7335 73.35%
Acute Oral Toxicity (c) II 0.7099 70.99%
Estrogen receptor binding + 0.8564 85.64%
Androgen receptor binding + 0.8559 85.59%
Thyroid receptor binding - 0.5197 51.97%
Glucocorticoid receptor binding + 0.8658 86.58%
Aromatase binding + 0.5292 52.92%
PPAR gamma + 0.8138 81.38%
Honey bee toxicity - 0.9542 95.42%
Biodegradation - 0.9000 90.00%
Crustacea aquatic toxicity - 0.5700 57.00%
Fish aquatic toxicity + 0.9638 96.38%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.46% 91.11%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 93.95% 94.45%
CHEMBL1806 P11388 DNA topoisomerase II alpha 91.89% 89.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.90% 95.56%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 88.44% 94.00%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 87.89% 99.15%
CHEMBL3194 P02766 Transthyretin 87.32% 90.71%
CHEMBL2581 P07339 Cathepsin D 86.52% 98.95%
CHEMBL1951 P21397 Monoamine oxidase A 83.62% 91.49%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 83.45% 99.23%
CHEMBL3401 O75469 Pregnane X receptor 83.28% 94.73%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 83.27% 90.71%
CHEMBL1293255 P15428 15-hydroxyprostaglandin dehydrogenase [NAD+] 83.12% 83.57%

Plants that contains it

Top

Cross-Links

Top
PubChem 5317297
NPASS NPC203654